SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-025298
Filing Date
2021-11-04
Accepted
2021-11-04 16:31:20
Documents
86
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbyi20210930_10q.htm   iXBRL 10-Q 1385181
2 EXHIBIT 10.1 ex_301580.htm EX-10.1 1119141
3 EXHIBIT 31.1 ex_287369.htm EX-31.1 8213
4 EXHIBIT 31.2 ex_287370.htm EX-31.2 8212
5 EXHIBIT 32.1 ex_287371.htm EX-32.1 4974
6 EXHIBIT 32.2 ex_287372.htm EX-32.2 4992
  Complete submission text file 0001437749-21-025298.txt   8855384

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20210930.xsd EX-101.SCH 74352
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20210930_cal.xml EX-101.CAL 71676
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20210930_def.xml EX-101.DEF 486411
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20210930_lab.xml EX-101.LAB 444361
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20210930_pre.xml EX-101.PRE 526041
12 EXTRACTED XBRL INSTANCE DOCUMENT pbyi20210930_10q_htm.xml XML 1182820
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 211380469
SIC: 2834 Pharmaceutical Preparations